Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | EW | LLY |
|---|
| Close | 92.01 | 1,417.54 |
| Market Cap | $53.6B | $1.34T |
| 1M | +6.59% | +22.51% |
| P/E (TTM) | 53.7 | 50.2 |
| Forward P/E | 31.0 | 26.3 |
| P/E 5-Yr Percentile | 100 | 28 |
| P/S | 8.3 | 16.8 |
| P/B | 5.1 | 39.6 |
| Dividend Yield | — | 0.75% |
| Latest Quarter Revenue | $1.7B | $24.4B |
| Revenue YoY | +13.6% | +38.6% |
| Gross Margin | 77.5% | 83.9% |
| Latest Quarter EPS | 0.42 | 7.22 |
| Avg Post-Earnings Move | ±3.9% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | 2 / 2 | — |
| Shareholder Yield | 2.25% | 0.88% |
| 90-Day Net Insider Buying | −$3.5M | −$16.0M |
EW · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
